EUVIMEDEUVIMED entdecken
Übersichtsarbeit

HER2-low across solid tumours: different incidences and definitions

Ximena Baez-Navarro, Floris H Groenendijk, Lindsey Oudijk, Jan von der Thüsen, Nicola Fusco, Giuseppe Curigliano, Carolien H M van Deurzen

Pathology · 2025-06 · 57 (4) · 403-414

DOI: 10.1016/j.pathol.2025.02.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology, 2025-06. Verfasst von Ximena Baez-Navarro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: x.baeznavarro@erasmusmc.nl. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: Roche, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesNeoplasmsHumansFemaleBiomarkers, TumorTrastuzumabImmunohistochemistryGene AmplificationBreast NeoplasmsImmunoconjugatesIncidenceCamptothecin

Stichwörter der Autor:innen

HER2-expressionHER2-lowNSCLCbreast cancergastro-oesophageal cancergene amplificationgynaecological cancerimmunohistochemistryin situ hybridisation

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorTrastuzumabImmunoconjugatesCamptothecinERBB2 protein, humantrastuzumab deruxtecan

Autor:innen und Institutionen

  • Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: x.baeznavarro@erasmusmc.nl.
  • Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.
  • Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.

Förderung

  • Roche
  • AstraZeneca

Zitieren

APA

Baez-Navarro, X., Groenendijk, F. H., Oudijk, L., von der Thüsen, J., Fusco, N., Curigliano, G., & van Deurzen, C. H. M. (2025). HER2-low across solid tumours: different incidences and definitions. Pathology, 57(4), 403-414. https://doi.org/10.1016/j.pathol.2025.02.003

Vancouver

Baez-Navarro X, Groenendijk FH, Oudijk L, von der Thüsen J, Fusco N, Curigliano G, et al. HER2-low across solid tumours: different incidences and definitions. Pathology. 2025;57(4):403-414. doi:10.1016/j.pathol.2025.02.003

BibTeX
@article{BaezNavarro2025,
  author = {Baez-Navarro, Ximena and Groenendijk, Floris H and Oudijk, Lindsey and von der Thüsen, Jan and Fusco, Nicola and Curigliano, Giuseppe and van Deurzen, Carolien H M},
  title = {HER2-low across solid tumours: different incidences and definitions},
  journal = {Pathology},
  year = {2025},
  volume = {57},
  number = {4},
  pages = {403--414},
  doi = {10.1016/j.pathol.2025.02.003}
}
Kostenlos starten →